JPRN-UMIN000000978已完成1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancer - Phase I study of DCS therapy for advanced gastric cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Active infection 2. Severe peritoneal metastasis 3. Massive pleural effusion 4. CNS metastasis 5. Severe diarrhea 6. Suspected of Interstitial Pneumonitis 7. Other severe complications 8. Active malignancy 9. Pregnant
研究者
相似试验
已完成
1 期
Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Canceruntreated advanced or recurrent gastric cancerJPRN-UMIN000000484Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama40
招募中
2 期
Phase II study of DCS-Tgastric cancerJPRN-jRCTs061180096Takayama Tetsuji30
已完成
1 期
Phase 1 study of Docetaxel and Oxaliplatin and TS-1 for unresectable / recurrent gastric cancer (KOGC-06)unresectable / recurrent gastric cancerJPRN-UMIN000015723Keio University School of Medicine, Department of Surgery5
招募中
不适用
Phase 2 study of S-1, docetaxel, cisplatin and trastuzumab combination chemotherapy (DCS-T) in patients with HER2-positive unresectable metastatic gastric cancergastric cancerJPRN-UMIN000012042Tokushima-Hokkaido cancer therapy clinical trial group30
招募中
1 期
DOS studygastric cancerJPRN-jRCTs061180095Takayama Tetsuji30